Alyssa Smith
Medical · Salt Lake City, UTNPI 1407321680
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,699 and has fallen 54.2% since, to $777 in 2025. Among medical clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $21.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$1K
- Amgen$467
- Lilly USA, LLC$458
- Boehringer Ingelheim$450
- Sanofi-aventis U.S. LLC$385
- Corcept Therapeutics$382
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,349100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 22 | $1,095 |
| Amgen | 32 | $467 |
| Lilly USA, LLC | 32 | $458 |
| Boehringer Ingelheim | 23 | $450 |
| Sanofi-aventis U.S. LLC | 14 | $385 |
| Corcept Therapeutics | 15 | $382 |
| Merck | 21 | $343 |
| Xeris Pharmaceuticals, Inc. | 10 | $213 |
| AbbVie | 10 | $193 |
| Bayer | 10 | $168 |
| Novartis | 9 | $167 |
| GSK | 7 | $113 |
| Astellas Pharma US Inc | 5 | $111 |
| Viiv Healthcare Company | 3 | $77 |
| Boston Scientific | 1 | $76 |
| Novo Nordisk | 5 | $73 |
| Paratek Pharmaceuticals, Inc. | 4 | $64 |
| AstraZeneca | 4 | $52 |
| Pfizer | 3 | $52 |
| Lifescan, Inc. | 3 | $47 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Lucid Diagnostics Inc. | 3 | $43 |
| Ascensia Diabetes Care US Inc. | 2 | $40 |
| Globus Medical | 1 | $32 |
| Amarin Pharma, Inc. | 2 | $30 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| La Jolla Pharmaceutical Company | 1 | $21 |
| Edwards Lifesciences | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$762
- TZIELD$125
How this compares
$5,360 in reported general payments places this provider in the 90th percentile of 263 medical providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $26,982 |
| TrulicityDulaglutide | 12 | $21,787 |
| MounjaroTirzepatide | 11 | $10,275 |
| TradjentaLinagliptin | 16 | $8,900 |
| JardianceEmpagliflozin | 11 | $6,794 |
| Levothyroxine Sodium | 127 | $1,413 |
| ValacyclovirValacyclovir Hcl | 27 | $1,384 |
| Gabapentin | 77 | $1,339 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 67 | $1,267 |
| Omeprazole | 82 | $1,135 |
| Atorvastatin Calcium | 106 | $890 |
| Potassium Chloride | 34 | $813 |
| Metoprolol Succinate | 42 | $767 |
| Rosuvastatin Calcium | 68 | $759 |
| Amlodipine Besylate | 58 | $718 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $458 | $32,06223 claims |
| PfizerEliquis | $52 | $26,98218 claims |
| Boehringer IngelheimTradjenta, Jardiance | $450 | $15,69327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 263 medical providers in Utah.
Other medical in Salt Lake City
- Elisa WilcoxSalt Lake City$178K
- Viet leSalt Lake City$42K
- Carmelo DiazSalt Lake City$35K
- Shari CombeSalt Lake City$22K
- Abbie SiebenhaarSalt Lake City$7K
- Gerald KeltySalt Lake City$6K
- Alanna JorgensenSalt Lake City$6K
- Michael SwinyerSalt Lake City$5K
- Louise TobeySalt Lake City$5K
- Jessica LathamSalt Lake City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.